Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 1, 2000American Journal of Clinical PathologyOpen Access

HER-2/neu Protein Expression in Breast Cancer Evaluated by Immunohistochemistry

View Full Paper
Ask AI
Bookmark
Share

Authors

TJTimothy W. JacobsJacobs (United States)AGAllen M. GownUniversity of British ColumbiaHYHadi YazijiYazd University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Jacobs et al. (2000) studied this question.

synapsesocial.com/papers/6a7d7c2e711f6884878c8cd9https://doi.org/10.1309/980m-e24r-v19k-595d
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Should Selection of Adjuvant Chemotherapy for Patients With Breast Cancer Be Based on erbB-2 Status?1998 · 65 citations
  2. 2Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment.1998 · 1,078 citations